drugset / Trial / NCT03103074
Pilot Study on Botulinum Toxin B as Treatment for Hidradenitis Suppurativa
Completed
20 enrolled
University Hospital of North Norway
Hidrosis Clinic, Stockholm, Sweden · collabThe Royal Norwegian Ministry of Health · collab
RandomizedCrossoverTriple-blindTreatment
Summary
Randomized double blind placebo controlled pilot study/proof of concept-study to see if intradermal injection with Botulinum toxin B is an effective treatment of Hidradenitis suppurativa
Timeline
- Start
- 2017-06-01
- Primary completion
- 2018-03-23
- Completion
- 2018-09-23
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Botulinum Toxin Type B | Unknown | 50 iu | Other |